For a patient on low‑dose aspirin (81 mg) scheduled for elective spine surgery, how many days should aspirin be discontinued preoperatively, and are there exceptions (e.g., recent myocardial infarction, coronary stent placement, high‑risk cardiac history) where aspirin should be continued?

Perioperative Aspirin Management in Spine Surgery

For most patients on low-dose aspirin (81 mg) undergoing elective spine surgery, aspirin should be continued throughout the perioperative period unless the procedure involves closed-space surgery with high bleeding risk, in which case it should be discontinued 7-10 days preoperatively. However, patients with recent coronary stents, recent myocardial infarction, or high thrombotic risk should continue aspirin regardless of bleeding risk.

Decision Algorithm Based on Cardiac Risk Profile

Patients WITH Prior Coronary Stenting

Continue aspirin throughout the perioperative period 1. The 2024 AHA/ACC guidelines provide Class I (strongest) recommendation that aspirin (75-100 mg) should be continued in patients with prior PCI undergoing noncardiac surgery to reduce cardiac events 1.

Critical timing considerations:

• Drug-eluting stent (DES) placed for acute coronary syndrome: Surgery should ideally be delayed ≥12 months 1
• DES placed for stable coronary disease: Delay surgery ≥6 months if possible 1
• Time-sensitive surgery: May proceed ≥3 months after DES if surgical benefits outweigh MACE risk 1
• Within 30 days of any stent placement: Elective surgery is potentially harmful and should be avoided 1

If dual antiplatelet therapy (DAPT) must be interrupted, aspirin should be continued as monotherapy and the P2Y12 inhibitor restarted immediately postoperatively 2.

Patients WITHOUT Prior Coronary Stenting

For patients with established coronary artery disease (CAD): It may be reasonable to continue aspirin when cardiac event risk outweighs bleeding risk 1. The 2024 guidelines give this a Class 2b recommendation, indicating moderate uncertainty but leaning toward continuation in selected high-risk patients.

For patients using aspirin for primary prevention only: Discontinue aspirin 7-10 days preoperatively 3, 4. These patients lack the high thrombotic risk that justifies bleeding risk.

Bleeding Risk Considerations in Spine Surgery

The spine surgery literature shows conflicting data, but the most rigorous evidence suggests:

• Continuation appears safe in most cases: A 2015 cohort study of 200 spine surgery patients found no epidural hematomas and no significant difference in blood loss between aspirin continuation versus discontinuation groups 5. Patients continuing aspirin actually had shorter hospital stays and operative times.

• Meta-analysis supports safety: A 2017 meta-analysis found no significant differences in perioperative blood loss (554 mL vs 539 mL), operative time, or complications between continuation and discontinuation groups 6.

• Timing matters if discontinuing: Multiple studies confirm increased bleeding if aspirin stopped only 3-7 days preoperatively, but no increased risk if stopped 7-10 days before surgery 3, 4.

Specific Exceptions Requiring Aspirin Continuation

Absolute indications to continue aspirin regardless of bleeding risk:

1. Recent myocardial infarction (within 12 months, especially if stented) 1
2. Coronary stent of any type (bare-metal or drug-eluting) 1, 2
3. Recent stroke or TIA with aspirin as secondary prevention
4. High GRACE score or documented high thrombotic risk

Relative indications favoring continuation:

• Established CAD with prior MI (>12 months ago)
• Multiple cardiovascular risk factors
• Peripheral arterial disease
• Cerebrovascular disease

Closed-Space Surgery Exception

For intracranial or other closed-space procedures where even minor bleeding could cause catastrophic neurological injury, aspirin discontinuation 7-10 days preoperatively is reasonable even in high-risk cardiac patients 3, 4. This represents the one scenario where bleeding risk may outweigh thrombotic risk.

Common Pitfalls to Avoid

1. Do not stop aspirin only 3-5 days preoperatively - this timing provides neither adequate platelet recovery nor thrombotic protection 3

2. Do not defer to cardiology "clearance" alone - cardiologists may not appreciate spine-specific bleeding risks. The 2014 ACC/AHA guidelines explicitly state management should involve consensus between surgeon, anesthesiologist, and cardiologist 2

3. Do not assume all spine surgery has equal bleeding risk - minimally invasive procedures have lower risk than multilevel decompressions with instrumentation

4. Do not forget to restart aspirin postoperatively - if discontinued, resume as soon as hemostasis is secure, typically within 24-48 hours

Practical Implementation

For the typical patient on 81 mg aspirin for primary prevention undergoing elective lumbar decompression:

• Stop aspirin 10 days preoperatively
• Proceed with surgery
• Restart aspirin postoperative day 1-2 once surgical hemostasis confirmed

For a patient with DES placed 8 months ago for acute MI:

• Continue aspirin 81 mg throughout
• Ensure adequate hemostasis intraoperatively
• Accept slightly higher bleeding risk to prevent stent thrombosis
• Consider delaying surgery to 12 months if truly elective

The 2024 AHA/ACC guidelines 1 represent the most authoritative and recent evidence, superseding older recommendations that routinely discontinued all antiplatelet therapy before surgery.